drugset / Trial / NCT06184269
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"
RandomizedCrossoverDouble-blindTreatment
Summary
The objective of this clinical study is to evaluate the pharmacokinetics and the safety after administration of "BR1017-1" and co-administration of "BR1017-1A" and "BR1017-1B" in healthy volunteers
Timeline
- Start
- 2023-12-23
- Primary completion
- 2024-02-18
- Completion
- 2024-02-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR1017-1 | Unknown | — | — |
| Comparator | BR1017-1A | Unknown | — | — |
| Comparator | BR1017-1B | Unknown | — | — |